Palvella Therapeutics (PVLA) Cash from Investing Activities (QoQ) (2014 - 2024)
Palvella Therapeutics (PVLA) Cash from Investing Activities (QoQ) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Palvella Therapeutics | 1.88 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -93.47% |
| Jun 30, 2024 | -75.82% |
| Mar 31, 2024 | 160.95% |
| Dec 31, 2023 | 273.84% |
| Sep 30, 2023 | -45.24% |
| Jun 30, 2023 | -111.48% |
| Mar 31, 2023 | 975.25% |
| Dec 31, 2022 | -79.76% |
| Sep 30, 2022 | 150.35% |
| Jun 30, 2022 | 35.89% |
| Mar 31, 2022 | -4,855.56% |
| Dec 31, 2021 | 2.29% |
| Sep 30, 2021 | -52.84% |
| Jun 30, 2021 | -717.86% |
| Mar 31, 2021 | -100.19% |
| Dec 31, 2020 | -19.07% |
| Sep 30, 2020 | 227.93% |
| Jun 30, 2020 | 1,251.69% |
| Mar 31, 2020 | 122.01% |
| Dec 31, 2019 | -145.62% |